No Data
No Data
CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Maintains Target Price $41
Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI)
Implied Volatility Surging for STAAR Surgical (STAA) Stock Options
STAAR Surgical To Present At Canaccord Genuity Growth Conference; Webcast At 8:30 AM ET
The Three-year Loss for STAAR Surgical (NASDAQ:STAA) Shareholders Likely Driven by Its Shrinking Earnings
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Staar Surgical (STAA) and Organon (OGN)
No Data